TP53 and leukemia: The apoptotic chemotherapy response and transcriptional induction of pro-apoptotic p53 target genes seen in treated E177R leukemia cells were rather unexpected, given that various partial-LOF mutants, including E177R, were previously described to have a selective apoptosis defect [16, 28, 30, 44–46].